DH — Definitive Healthcare Share Price
Last trade - 00:00- $858.17m
- $1.15bn
- $251.42m
- 51
- 27
- 16
- 22
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 14.39 | ||
| PEG Ratio (f) | 0.24 | ||
| EPS Growth (f) | 149.75% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 21.05 | ||
| Price to Sales | 3.37 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -20.29% | ||
| Return on Equity | -21.67% | ||
| Operating Margin | -130.54% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 85.5 | 118.32 | 166.15 | 222.65 | 251.41 | 258.28 | 272.8 | 30.95% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | +7.34 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Definitive Healthcare Corp. is engaged in transforming data, analytics, and expertise into healthcare commercial intelligence. The Company’s solutions are designed to provide information on healthcare providers and their activities to help its customers optimize everything from product development to go-to-market planning and sales and marketing execution. Its software-as-a-service (SaaS) platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers and improving win rates with detailed contextual information. It transforms data into intelligence through artificial intelligence (AI) and machine learning (ML) algorithms that ingest, cleanse, link, and analyze the data to create new intelligence and analytics. All of its business is conducted through AIDH TopCo, LLC (Definitive OpCo).
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- May 5th, 2021
- Public Since
- September 15th, 2021
- No. of Shareholders
- 34
- No. of Employees
- 830
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 157,173,545
- Address
- 492 Old Connecticut Path, Suite 401, FRAMINGHAM, 01701
- Web
- https://ir.definitivehc.com/
- Phone
- +1 5087204224
- Auditors
- Deloitte & Touche LLP
Latest News for DH
Upcoming Events for DH
Q2 2024 Definitive Healthcare Corp Earnings Release
Q3 2024 Definitive Healthcare Corp Earnings Release
Similar to DH
2U
NASDAQ Global Select Market
ACV Auctions
NASDAQ Global Select Market
Adeia
NASDAQ Global Select Market
Adobe
NASDAQ Global Select Market
Agilysys
NASDAQ Global Select Market
FAQ
As of Today at 20:15 UTC, shares in Definitive Healthcare are trading at $5.48. This share price information is delayed by 15 minutes.
Shares in Definitive Healthcare last closed at $5.48 and the price had moved by -44.02% over the past 365 days. In terms of relative price strength the Definitive Healthcare share price has underperformed the S&P500 Index by -55.46% over the past year.
The overall consensus recommendation for Definitive Healthcare is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Definitive Healthcare does not currently pay a dividend.
Definitive Healthcare does not currently pay a dividend.
Definitive Healthcare does not currently pay a dividend.
To buy shares in Definitive Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $5.48, shares in Definitive Healthcare had a market capitalisation of $861.31m.
Here are the trading details for Definitive Healthcare:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: DH
Based on an overall assessment of its quality, value and momentum Definitive Healthcare is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Definitive Healthcare is $8.61. That is 57.12% above the last closing price of $5.48.
Analysts covering Definitive Healthcare currently have a consensus Earnings Per Share (EPS) forecast of $0.37 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Definitive Healthcare. Over the past six months, its share price has underperformed the S&P500 Index by -51.09%.
As of the last closing price of $5.48, shares in Definitive Healthcare were trading -29.41% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Definitive Healthcare PE ratio based on its reported earnings over the past 12 months is 14.39. The shares last closed at $5.48.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Definitive Healthcare's directors